Keyphrases
Evidence-based Treatment
100%
Critical Limb Ischemia
100%
Use of Evidence
100%
Myocardial Infarction
85%
Confidence Interval
57%
Angiotensin Receptor Blockers
21%
Angiotensin-converting Enzyme Inhibitor (ACEi)
21%
Lipid-lowering Agents
21%
Odds Ratio
7%
Hazard Ratio
7%
AIMS™
7%
Danish Registry
7%
Comorbidity
7%
Hospitalization
7%
Mortality Rate
7%
Adjusted Analysis
7%
Clinical High Risk
7%
Overall Mortality
7%
Adverse Prognosis
7%
Antiplatelet
7%
Survivors
7%
History of Myocardial Infarction
7%
Undertreated
7%
Practice Patterns
7%
Medicine and Dentistry
Ischemia
100%
Combination Therapy
100%
Limb
100%
Myocardial Infarction
92%
Hypolipidemic Agent
21%
Angiotensin Receptor Antagonist
21%
ACE Inhibitor
21%
Mortality Rate
7%
Odds Ratio
7%
Hazard Ratio
7%
Identified Patient
7%
Antiplatelet
7%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Angiotensin Receptor
100%
Lipid
100%
Enzyme Inhibitor
100%
Comorbidity
33%
Mortality Rate
33%
Nursing and Health Professions
Combination Therapy
100%
Ischemia
100%
Heart Infarction
92%
Confidence Interval
57%
Antilipemic Agent
21%
Angiotensin Receptor Antagonist
21%
Dipeptidyl Carboxypeptidase Inhibitor
21%
Practice Guideline
7%
Comorbidity
7%
Mortality Rate
7%
Odds Ratio
7%
Hazard Ratio
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemia
100%
Combination Therapy
100%
Heart Infarction
92%
Angiotensin Receptor Antagonist
21%
Antilipemic Agent
21%
Dipeptidyl Carboxypeptidase Inhibitor
21%
Comorbidity
7%
Mortality Rate
7%
Antiplatelet
7%
Neuroscience
Ischemia
100%
Myocardial Infarction
92%
Angiotensin Receptor
21%
ACE Inhibitor
21%
Hypolipidemic Agent
21%